Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-18 Sale | 2025-02-19 4:36 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 244 | $455.06 | $111,035 | 67,695 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 4:28 pm | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 1,657 | $455.06 | $754,034 | 17,606 (Direct) | View |
| 2025-02-18 Sale | 2025-02-19 4:21 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 671 | $455.06 | $305,345 | 10,798 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:50 pm | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 310 | $459.83 | $142,547 | 64,021 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:36 pm | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 3,433 | $459.87 | $1,578,734 | 16,330 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:29 pm | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,747 | $459.83 | $803,323 | 23,225 (Direct) | View |
| 2025-02-11 Sale | 2025-02-12 4:24 pm | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 1,376 | $459.83 | $632,726 | 9,953 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-02-14 Tax Withholding | 2025-02-19 4:38 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 2,293 | $463.46 | 63,241 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:36 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,293 | $463.46 | 67,695 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:34 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 2,139 | $463.46 | 75,545 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:33 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 6,066 | $463.46 | 24,466 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:31 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 6,553 | $463.46 | 129,380 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:30 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 1,912 | $463.46 | 40,941 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:28 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 1,504 | $463.46 | 17,606 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:26 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 1,529 | $463.46 | 27,907 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:25 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 2,724 | $463.46 | 74,862 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 564 | $463.46 | 10,798 (Direct) | View |
| 2025-02-14 Tax Withholding | 2025-02-19 4:19 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 2,293 | $463.46 | 46,130 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 6,655 | $0 | 65,534 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:18 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 6,211 | $0 | 70,232 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:17 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 7,209 | $0 | 30,532 (Direct) | View |
| 2025-02-13 Tax Withholding | 2025-02-14 4:17 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 2,525 | $450.83 | 30,532 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:14 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 6,211 | $0 | 77,684 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:13 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 19,015 | $0 | 135,933 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:11 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 5,546 | $0 | 42,853 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:10 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 4,437 | $0 | 20,767 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:08 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 6,211 | $0 | 29,436 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:06 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 7,903 | $0 | 77,586 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:04 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 2,080 | $0 | 12,033 (Direct) | View |
| 2025-02-12 Option Award | 2025-02-14 4:03 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 5,324 | $0 | 48,423 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:52 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 2,649 | $467.98 | 58,879 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:50 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 2,143 | $467.98 | 64,021 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:48 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 2,056 | $467.98 | 71,473 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:46 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 8,300 | $467.98 | 116,918 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:38 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 2,142 | $467.98 | 37,307 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:36 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 1,632 | $467.98 | 16,330 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:29 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 876 | $467.98 | 23,225 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:26 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO | 3,220 | $467.98 | 69,683 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:24 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer | 591 | $467.98 | 9,953 (Direct) | View |
| 2025-02-10 Tax Withholding | 2025-02-12 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | ALTSHULER DAVID EVP, Chief Scientific Officer | 2,142 | $467.98 | 43,099 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 4:45 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer | 17,376 | $0 | 61,528 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 4:43 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Tatsis Ourania EVP, Chief Reg. & Quality Off. | 17,376 | $0 | 66,474 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 4:41 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Sachdev Amit EVP Chief Patient & Ext Af Off | 15,324 | $0 | 73,529 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 4:38 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman | 15,414 | $0 | 25,848 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 4:37 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President | 49,446 | $0 | 125,218 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 4:35 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO | 16,190 | $0 | 39,449 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 4:32 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Biller Jonathan EVP and Chief Legal Officer | 4,744 | $0 | 21,395 (Direct) | View |
| 2025-02-04 Option Award | 2025-02-06 4:21 pm | N/A N/A | VERTEX PHARMACEUTICALS INC | VRTX | Atkinson Edward Morrow III EVP, Chief Technical Ops. Off. | 9,876 | $0 | 25,848 (Direct) | View |